Antivirals

   
 
Table 7-2 Oral Antiviral Drugs
 
Name
Mechanism of Action
Spectrum, Pregnancy Category
Miscellaneous
 
Acyclovir
Phosphorylated by viral thymidine kinase to acyclovir monophosphate, which blocks viral DNA polymerase → stops viral DNA synthesis
Herpes simplex virus (HSV), varicella- zoster virus (VZV)

Pregnancy category B
SE: IV infusion associated with reversible obstructive nephropathy, rarely may see severe CNS Pregnancy category B changes (i.e., seizures)
 
Valacyclovir
Prodrug of acyclovir, same mechanism of action (viral thymidine kinase-dependent activity)
HSV, VZV, cytomegalovirus (CMV)

Category B
Better bioavailability than acyclovir

SE: TTP/HUS* seen in advanced HIV disease and transplant patients taking high doses
 
Penciclovir
Phosphorylated by viral thymidine kinase (similar mechanism to acyclovir)
HSV, VZV
Low bioavailability so typically used in topical form
 
Famciclovir
Prodrug of penciclovir with same mechanism as above
HSV, VZV

Category B
Better bioavailability than Category B penciclovir
 
Ganciclovir
Phosphorylated by viral thymidine kinase; same mechanism as above
CMV (retinitis)

Category C
Better activity against CMV than acyclovir; ↓ oral bioavailability

SE: neutropenia, bone marrow suppression, mucositis, thrombocytopenia, seizures hepatic dysfunction
 
Foscarnet
Noncompetitive inhibition of viral DNA polymerases; analogue of pyrophosphate

Does not require phosphorylation so active against acyclovir-resistant viruses
CMV (retinitis), resistant HSV, resistant VZV

Category C
Only IV form; active against infections resistant to acyclovir, famciclovir, ganciclovir

SE: penile ulcerations or erosions, nephrotoxicity
 
Cidofovir
Nucleoside analogue, inhibits viral DNA polymerase, independent of thymidine kinase activation
CMV

Category C
IV only; active against infections resistant to ganciclovir/foscarnet

SE: renal proteinuria, renal toxicity, ↑ creatinine
 
Amantidine,
Rimantidine
Inhibit uncoating of viral DNA within infected host cells (prevents replication)
Influenza A/C, rubella

Category C
SE: anticholinergic symptoms, Category C ataxia, and photosensitivity
        
        
 *TTP: thrombotic thrombocytopenic purpura
HUS: hemolytic uremic syndrome
 
   
   
 
Table 7-3 Antiretroviral Drugs
 NameMechanism of ActionCharacteristics
Nucleoside/nucleotide reverse transcriptase inhibitors
 
Zidovudine (AZT)
Thymidine analogue, inhibits HIV reverse transcriptase (RT)
SE: melanonychia, mucocutaneous pigmentation, bone marrow suppression, lipodystrophy

Pregnancy category C
 
Didanosine (ddI)
Pyrimidine analogue, similar to AZT
SE: pancreatitis, optic neuritis, peripheral neuropathy, lactic acidosis; pregnancy category B
 
Abacavir (ABC)
Nucleoside RT inhibitor
SE: hypersensitivity reaction
(can be fatal upon rechallenge)

Pregnancy category C
 
Tenofovir
Nucleotide analogue, inhibits RT
Peripheral wasting, cushingoid appearance
Pregnancy category B
Protease inhibitors
 
Indinavir, Ritonavir, Lopinavir
Block HIV-1 protease enzymes
SE: lipodystrophy (buffalo hump), gynecomastia, periungual pyogenic granulomas, paronychia, hepatotoxicity